Stock Earnings

Question 1

What are AIM ImmunoTech Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), AIM ImmunoTech Inc has a total asset of $8, Net loss of $-17

Question 2

What are the key financial ratios for AIM?

Accepted Answer

AIM ImmunoTech Inc's Current ratio is 0.88, has a Net margin is 0, sales per share of $0.

Question 3

How is AIM ImmunoTech Inc's revenue broken down by segment or geography?

Accepted Answer

AIM ImmunoTech Inc largest revenue segment is Ampligen and Other Drugs, at a revenue of 170,000 in the most earnings release.For geography, United States is the primary market for AIM ImmunoTech Inc, at a revenue of 170,000.

Question 4

Is AIM ImmunoTech Inc profitable?

Accepted Answer

no, according to the latest financial statements, AIM ImmunoTech Inc has a net loss of $-17

Question 5

Does AIM ImmunoTech Inc have any liabilities?

Accepted Answer

yes, AIM ImmunoTech Inc has liability of 9

Question 6

How many outstanding shares for AIM ImmunoTech Inc?

Accepted Answer

AIM ImmunoTech Inc has a total outstanding shares of 0.65

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	0	0	0	0	0	0
Gross Profit	0	0	0	0	0	0
Selling, General & Admin	11	14	21	13	8	8
Research & Development	4	5	10	6	7	5
Operating Expenses	16	19	32	20	16	14
Other Non Operating Income (Expenses)	--	--	--	0	0	0
Pretax Income	-16	-17	-28	-19	-19	-14
Income Tax Expense	--	--	--	--	--	--
Net Income	-16	-17	-28	-19	-19	-14
Net Income Growth	-43%	-39%	47%	0%	36%	56%
Shares Outstanding (Diluted)	0.75	0.56	0.48	0.48	47.34	31.84
Shares Change (YoY)	-99%	15%	1%	-99%	49%	774%
EPS (Diluted)	-21.29	-30.91	-59.61	-40.47	-0.4	-0.45
EPS Growth	3,917%	-48%	47%	9,917%	-11%	-82%
Free Cash Flow	-11	-14	-21	-16	-14	-10
Free Cash Flow Per Share	-14.48	-24.99	-43.21	-33.29	-0.29	-0.31
Gross Margin	0%	0%	0%	0%	0%	0%
Operating Margin	0%	0%	0%	0%	0%	0%
Profit Margin	0%	0%	0%	0%	0%	0%
Free Cash Flow Margin	0%	0%	0%	0%	0%	0%
EBITDA	-16	-19	-31	-19	-17	-15
EBITDA Margin	0%	0%	0%	0%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-16	-19	-31	-19	-17	-15
EBIT Margin	0%	0%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	--	--

AIM ImmunoTech Inc (AIM) Price

AIM Stock Price Chart

AIM Income

Follow-Up Questions